SGLT2 inhibitors and left atrial function in heart failure with reduced or mildly reduced ejection fraction
SGLT2 inhibitor use was not associated with significant improvement in LA volume or functional parameters in patients with HF and reduced or mildly reduced EF. The prognostic value of LA functions appears to be primarily influenced by diastolic dysfunction and ventricular remodeling rather than SGLT2 inhibitor therapy.
Authors
- Erhan Saraçoğlu (ORCID: https://orcid.org/0000-0003-3797-512X)
- Barış Dindar
- Hakan Duman (ORCID: https://orcid.org/0000-0002-1441-7320)
- Hüseyin Durak (ORCID: https://orcid.org/0000-0002-8248-5966)
- Elif Ergül (ORCID: https://orcid.org/0000-0003-3192-4719)
- Nadir Emlek (ORCID: https://orcid.org/0000-0003-0791-1248)
- Mustafa Çetın (ORCID: https://orcid.org/0000-0001-6342-436X)
- Müjgan Ayşenur Şahin (ORCID: https://orcid.org/0000-0003-3950-4911)
Institutions
- Recep Tayyip Erdoğan University (TR)
- Usak University (TR)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1186/s12872-025-05308-0
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00